Logo Join | About | Forum| Help | Bookmark | Login
Home Stories Groups People Marketplace | FREE Benefits
(Medical News Today) Novo Nordisk receives US approval for Victoza® (liraglutide) for the treatment of type 2 diabetes Novo Nordisk announced today that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza® for the treatment of type 2 diabetes in adults. Victoza® is the brand name approved in the US and Europe for liraglutide, the first once-daily human Glucagon-Like Peptide-1 ...
 
 
Tags: diabetes, diabete, diabetic-causes, diabetes-type-2, blood-sugar, diabetes-type-1, glucose, diabetes-symptoms
Posted By: Diabetes Posted Today
All Votes: 1
Bookmark
Comments (0) | Who voted on this story (1) | Email this story
 

UnitedProject.org Inc. (c) 2006-2010 All content published on UnitedProject.org is provided for informational purposes only and is not meant to substitute for the advice, diagnosis or treatment provided by your physician or other healthcare professionals. If you think you are experiencing a medical problem or an emergency please contact your physician, local emergency room or call 911. Healthcare benefits and discounts are not insurance and not intended as a substitute for health insurance. Except when other source is cited, all content posted by members is licensed under Creative Commons Public Domain License.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.


Site last updated 02/10/12 - loaded in 0.0560 seconds
Website and Case Management Software powered by Paas Cloud Computing Platform